AgroSpheres Inc., a leading biotechnology company at the forefront of sustainable agriculture, is proud to announce the addition of Nobel Prize winner Craig Mello to its advisory board. Dr. Mello’s...

Carta recently shared that the City of Charlottesville had the 10th highest amount of capital raised for medical device startups in the entire U.S., behind only a few major cities...

Caretaker Medical’s advanced hemodynamic monitoring devices are now available to military units and Veterans Affairs, up-leveling the care of U.S. soldiers and veterans. Caretaker Medical and Red One Medical have...

BioHealth Innovation, Inc. (BHI), a leading regional innovation intermediary, is thrilled to announce the five outstanding finalists for the 8th Annual BioHealth Capital Region Crab Trap competition. The Crab Trap...

BIO-CAT announced today that a newly published study on the probiotic Bacillus subtilis MB40 revealed promising results leading to the reduction of Listeria. The study was designed to determine the effects of Bacillus subtilis MB40 supplementation on...

 AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural and food technology markets, today announced the winners of its fourth...

Persistent supply challenges affecting continuous cardiac output (CCO) thermodilution catheters are impacting hospitals worldwide. In response, Caretaker Medical is ramping up efforts to increase awareness of its FDA-cleared wireless, wearable...

HemoSonics®, a medical device technology company focused on acute bleeding management, today announced its Quantra® Hemostasis System has received a Technology contract award from Vizient, Inc., the nation’s largest member-driven...

Symrise AG has signed a minority investment agreement with Bonumose. The early-stage food ingredient manufacturer specializes in the affordable production of delicious, good-for-you rare monosaccharides (alternatives to sucrose) such as...

RIVANNA®, developers of imaging-based medical solutions, announced that they have received funding totaling $30.5 million over 39 months from early execution of an option by the Biomedical Advanced Research and...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), has presented positive...

Thomas Barker says his seed-stage startup wants to find “modern, modular, functional lab space” to allow the company he co-founded, Vasarya Therapeutics, to be “very efficient and optimal on our...